The Japanese Journal of Antibiotics
Online ISSN : 2186-5477
Print ISSN : 0368-2781
ISSN-L : 0368-2781
A CLINICAL STUDY OF COMBINED THERAPY OF ASPOXICILLIN AND CEFTAZIDIME ON INTRACTABLE RESPIRATORY INFECTIONS
KENICHI YAMAKIRYUJIRO SUZUKIFUMIO TAKIKENZO TAKAGITATSUO SATAKEKATSUYUKI MIZUNOKENJI BABAHIROSHI AIHARAMASANORI MORIKENJI YAMADAMASAHIKO ISHIKAWAMICHIHIRO HARASHUICHI MATSUMOTOTAKASHI ARAIMASATOSHI IMAITOSHIAKI KAKUTAMASAO TANOMASARU IWATAHIROYUKI NOSAKAMOTOHIDE SASAMOTOHIDEHIKO FURUIMITSUYASU ITOHIROYUKI MIYATAKEHIDEO GONDAYASUNOBU NODA
Author information
JOURNAL FREE ACCESS

1992 Volume 45 Issue 10 Pages 1282-1294

Details
Abstract
Both aspoxicillin (ASPC) and ceftazidime (CAZ) were administerted together to 55 patients with intractable respiratory tract infections. ASPC and CAZ were administerted at daily doses of 4g and 2 to 4g, respectively. Clinical effects were excellent in 11 cases, good in 33, fair in 7 and poor in 4, thus the efficacy rate was 80.0%. Bacteriologically, identified organisms were eradicated in 14 cases out of 21, decreased in 3, exchanged in 2 and unchanged in 2. The eradication rate was 76.2%. As a side effect, diarrhea was found in only one case, and abnormal laboratory test values were observed in 4 cases. However, these adverse reactions were not severe, therefore it was possible to continue the chemotherapy.
These results indicate that the combination antimicrobial chemotherapy of ASPC and CAZ is effective against intractable respiratory tract infections.
Content from these authors
© Japan Antibiotics Research Association
Previous article Next article
feedback
Top